
Christoph_Oing
@oingc1
Med Onc at UKE Hamburg. @myESMO #ESMOYOC member, former @myESMO fellow. GU cancer specialist. Focus early phase trials 🎯💊 / translational research 🧬🧫🔬.
ID: 1439292714177245189
18-09-2021 18:18:30
36 Tweet
186 Followers
220 Following

#ESMO21: Results from the SAKK 01/10 trial demonstrate favourable PFS and low toxicity with single-dose carboplatin and involved-node #radiotherapy. 👉ow.ly/Vixs50GcwVz #tscsm #seminoma Robert Huddart💙


Join me and Dr Donna Graham discussing the impact of Covid19 on early phase trials tomorrow ESMO - Eur. Oncology #MAP2021 conference! Let's discuss the lessons learned and where can we go next? 🤓👩🏫 PS! #MAP2021 is free for all ESMO members😉

among many others incredible speakers jim catto Laurence Albiges Gianluca Giannarini alberto briganti Francesco Montorsi Christoph_Oing silke gillessen Maria De Santis Piet Ost Morgan Roupret prof. Stefano Fanti Declan Murphy Anwar Padhani Philip Cornford Pierre Blanchard, MD steven joniau Veeru Kasi Axel S. Merseburger Stéphane Oudard

New #ESMOYOC Virtual #Mentorship session for #medicalstudents & new physicians on ESMO activities for medical students, poster prep & presentation, & virtual poster walk 🙌 11 Nov 17:00 CET 👉 Join us (free) ow.ly/5ofc50GA0LJ Teresa Amaral, MD, PhD Rille Pawel Sobczuk


Don't forget to apply to this amazing program! 😊 #virtualmentorship #careerdevelopment ESMO - Eur. Oncology #esmoyoc Jon Lim, MRCP PhD Matteo Lambertini, MD PhD Kevin Punie Pawel Sobczuk Elene Mariamidze Rille Maria Kfoury Christoph_Oing Claudia Cardone francescalongo Katharine Fumasoli

The #ESMOYOC virtual mentorship programme is open for applications. It's a great opportunity to be matched with ESMO - Eur. Oncology Leader for a 1:1 mentorship 12-months programme. Applications are open until Nov 21st. 👇esmo.org/career-develop…

All medical students and trainees interested in oncology- join us later today to see how #ESMO can help you in your career! ESMO - Eur. Oncology Teresa Amaral, MD, PhD Pawel Sobczuk

💥 So excited about the upcoming #ESMOYOC sessions at #ESMOasiaweek21: 🗓 Sun 21/11 - Adapting data from practice-changing studies into daily practice in Asia: Sherene Loi, MD Herbert Loong, MBBS, FASCO 🗓 Mon 22/11 - Running clinical trials in Asia: Tony Mok Hope to see you there. Don’t miss it!



Elena Castro #emuc21 describes the DDR biomarker for PARPi in prostate cancer. BRCA1/2 are the most relevant DNA alterations. ctDNA is an attractive alternative to archived tissue. DDR alterations occur early. PARPi has an important role in prostate cancer Christopher Sweeney, MBBS


#ESMOSarcoma22 starting tomorrow! 🚨Don't miss our sessions for young oncologists! 🔸Mentorship session (31/1, 17:30) with Jon Trent, MD, PhD César Serrano García 🔸Vesalius Talk: How to improve tx outcomes for #sarcoma pts? (1/2, 18:15) with @DrMehdiBrahmi Javier Martin Broto ESMO - Eur. Oncology OncoAlert



Soft Tissue #Sarcomas webinar airing in just a few hours. Register now and get your certificate of attendance and 1 ESMO-MORA point ⏰ 29/3, 18:30 CEST 🔗 ow.ly/7SV250Ity1E Alice Indini Silvia Stacchiotti Pawel Sobczuk Jean-Yves Blay #scmsm


Great opportunity to join us and study #radiosensitivity & #prostatecancer thanks to Prostate Cancer UK Work hard & play hard - it's translational & clinically relevant 🥳 Manchester Cancer Research Centre Division of Cancer Sciences @TheBACR ARR ESTRO David Wedge jobs.manchester.ac.uk/displayjob.asp…


#ESMO22 Come and join the ESMO YO Brunch session to discuss with Philippe Aftimos, MD about Molecular Tumor Boards at 11am in 7.3 Rennes!



Job for a clinical fellow helping with oncology trials Sir Bobby Robson Cancer Trials Research Centre NuTH Cancer Research (OHR). All previous incumbents have enjoyed themselves, built CVs and practiced baking amongst other skills beta.jobs.nhs.uk/candidate/joba…

#UROonco23 testis cancer session Christoph_Oing Alexandros Papachristofilou @Hielke_Martijn Maarten Albersen discussing the role of surgery chemotherapy and radiotherapy in stage 2 YAU Working Group Penile & Testis Cancer


New research from my MSNZ HaTriCs4 lab group UKE Hamburg. PCa patient-derived models to assess sensitivity to PARPi/CDDP.